Navigation Links
PharmAthene Provides Update on NYSE Amex Listing Compliance Plan
Date:7/30/2010

January 26, 2012.  If the NYSE Amex accepts the plan, PharmAthene will be able to continue its listing during such time and will be subject to continued periodic review by the NYSE Amex staff.  If the plan is not submitted on a timely basis, is not accepted or is accepted but PharmAthene does not make progress consistent with the plan during the plan period, the NYSE Amex could initiate delisting proceedings.  PharmAthene may appeal any delisting determination before a listings qualifications panel of the NYSE Amex and in turn request a review of the decision of such panel by the exchange's Committee on Securities.

PharmAthene intends to prepare and submit its compliance plan to the NYSE Amex.  PharmAthene expects that its common stock will continue to trade without interruption on the NYSE Amex; however, the trading symbol for PharmAthene's common stock will have an indicator (.BC) as an extension to signify noncompliance with the continued listing standards, until PharmAthene has regained compliance.

Eric Richman, PharmAthene's interim Chief Executive Officer, noted, "The NYSE Amex has not commenced any delisting proceedings against us and we are fully confident that our plan for continuing compliance will be adequate and that we will regain compliance with the affected listing requirements in the future."

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements tha
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PharmAthene Completes Previously Announced Registered Direct Offering
2. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
3. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
4. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
5. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
6. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
7. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
8. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
9. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
10. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
11. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Lilly and Company (NYSE: LLY ) announced today the ... up to $1.6 billion aggregate principal amount of certain of ... tendered, and did not validly withdraw, their notes on or ... time, on May 27, 2015 (the early tender date), and ... receive the total consideration. The total consideration for each series ...
(Date:5/28/2015)... and HOUSTON , May 28, 2015 ... EPI) today reported financial results for the second quarter and ... specified otherwise, are expressed in Canadian dollars and in accordance ... Results ESSA recorded a net loss of ... ended March 31, 2015 (Q2-2015), compared to a net loss ...
(Date:5/28/2015)... Research and Markets ( ... Jain PharmaBiotech,s new report  "RNAi - Technologies, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the use of double stranded RNA (dsRNA). ... processed into short 21-23 nucleotide RNAs termed ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... ( www.curemark.com ), a drug research and development company focused ... & Renshaw Annual Global Investment Conference held September 12-15 in ... 5,000 investors and other attendees.   "Curemark was ... present at the conference, which included a full roster of ...
... OmniComm Systems, Inc. (OTC Bulletin Board: ... and services announced that it will be hosting the ... Beach Resort in Fort Lauderdale, Florida from November 03-05, ... from participating Life Science organizations. The informal ambiance provides ...
Cached Medicine Technology:Curemark Presents at the Rodman & Renshaw Annual Global Investment Conference 2OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 2OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe is ... Joint Fluid Therapy (JFT) at their clinics in Orange ... injectable treatment that assists in diminishing pain for patients ... Dr. Stanley Katz and Dr. Neil Katz of Healthpointe. ... sodium hyaluronate (also known as hyaluronic acid) a natural ...
(Date:5/29/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 29, 2015 ... in the vulvar region and can cause significant physical, ... understands the major life altering disorder of Vulvodynia. The ... exclusion. At Women’s Excellence in Endometriosis, they realize that ... If a patient is experiencing any of these symptoms, ...
(Date:5/29/2015)... The popular all-natural supplement brand, Liporidex, ... Select Program that gives bonuses to members for their ... 100 members per year, lucky members who are selected ... fitness experts at Nuretix Research, and get exclusive benefits ... they attain and maintain their weight loss and fitness ...
(Date:5/29/2015)... Louisville, KY (PRWEB) May 29, 2015 ... private and government entities to discuss and foster the ... data to improve health. The Conference is hosted by ... government, non-profit, and private organizations to promote and develop ... conference, there are several focused groups to narrow in ...
(Date:5/29/2015)... External Counterpulsation, also known as EECP ... patients. The Heart Fit Clinic is the first clinic in ... review from patients who are now completing treatment. , ... treatments of ECP treatment and received great results. His ... does the clinic perform this non-surgical treatment for heart disease, ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Liporidex, a Sports Nutrition Supplement Brand, Is Searching For Members For Their Exclusive L-Style Select Program Which Rewards Members For Their Achievements 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2
... , , Web availability of ... CHARLESTON, S.C., Sept. 14 According to MUSC researchers, antibiotics ... despite efforts to control antibiotic-resistant bacteria as a result of misuse ... keyword search of "purchase antibiotics without a prescription" and "online" on ...
... , , , , ... A new critical illness plan from Colonial Life & Accident Insurance Company ... away from financial problems. Even with good health insurance, a serious illness, ... hook for huge expenses. , , "Even employees ...
... , , ROCKVILLE, Md., Sept. 14 ... Staying Active and Healthy with Blood Thinners , a new 10-minute ... to use anticoagulant drugs, commonly called blood thinners, safely. , ... thinners each year to reduce their risk of forming dangerous blood ...
... BOSTON, Sept. 14 Americans rate Alzheimer,s disease ... five million people living with this disease in the U.S. ... in the cause and prevention of Alzheimer,s disease, indicating that ... stave off this devastating illness. , , ...
... female patients , MONDAY, Sept. 14 (HealthDay News) -- ... with advanced heart failure. , A new analysis turns ... and then correct abnormal heart rhythms, actually lowered the ... that this is routine therapy for all patients with ...
... of other cancers, clots , MONDAY, Sept. 14 (HealthDay ... for developing breast cancer do reduce their cancer risk, ... analysis suggests. , That was the conclusion of researchers ... trials and a head-to-head assessment of the medications used ...
Cached Medicine News:Health News:MUSC Researchers Concerned About Online Drug Availability 2Health News:Critical Illness Plans Help Pay for What Health Insurance Won't 2Health News:Critical Illness Plans Help Pay for What Health Insurance Won't 3Health News:ahrq Announces New Video to Help Patients Use Blood Thinner Pills Safely and Effectively 2Health News:Senior Living Residences Launches Innovative Nutrition Program to Promote Cognitive Health and Lower the Risk of Alzheimer's Disease 2Health News:Implantable Defibrillators May Not Help Women With Heart Failure 2Health News:Implantable Defibrillators May Not Help Women With Heart Failure 3Health News:Medications That Lower Breast Cancer Risk Carry Other Dangers 2Health News:Medications That Lower Breast Cancer Risk Carry Other Dangers 3
... vascular tests for assessing peripheral vascular disease. With the Portable ABI Kit, you get the basic equipment ... ... ... The ankle-arm pressure index (also known as the Ankle/Brachial ...
... Clinitek Microalbumin Strips provide albumin, creatinine ... The Clinitek Microalbumin product is useful to ... or hypertension in order to detect early ... elevation of the urinary albumin excretion rate, ...
... today's busy physician's office environment, ... contribute to timing errors and ... strips are read visually. Studies ... is performed with an instrument, ...
... Ultra device consists of a non-compliant balloon ... mounted longitudinally on its outer surface. When ... the atherotomes score the plaque, creating initiation ... to as Atherotomy, allows dilatation of the ...
Medicine Products: